naphazoline has been researched along with Anisocoria in 1 studies
Naphazoline: An adrenergic vasoconstrictor agent used as a decongestant.
Anisocoria: Unequal pupil size, which may represent a benign physiologic variant or a manifestation of disease. Pathologic anisocoria reflects an abnormality in the musculature of the iris (IRIS DISEASES) or in the parasympathetic or sympathetic pathways that innervate the pupil. Physiologic anisocoria refers to an asymmetry of pupil diameter, usually less than 2mm, that is not associated with disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakatsuka, AS | 1 |
| Beaver, HA | 1 |
| Lee, AG | 1 |
1 other study available for naphazoline and Anisocoria
| Article | Year |
|---|---|
Mydriasis due to Opcon-A: An indication to avoid pharmacologic testing for anisocoria.
Topics: Adult; Anisocoria; Drug Combinations; Female; Histamine H1 Antagonists; Humans; Mydriasis; Naphazoli | 2018 |